Ruth E. Mirams
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ruth E. Mirams has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Gerhard Schenk
School of Chemistry and Molecular Biosciences, The University of Queensland, Australia
3 shared publications Sarah J. Smith
School of Molecular and Microbial Sciences, The University of Queensland, Queensland, Australia
3 shared publications- Lawrence. R. Gahan
School of Chemistry and Molecular Biosciences The University of Queensland Brisbane Queensland 4072 Australia
2 shared publications Lyall R. Hanton
Department of Chemistry, Te Tari Hua-Ruanuku, University of Otago, PO Box 56, Dunedin, New Zealand
2 shared publicationsAllan G. Blackman
Department of Chemistry, Te Tari Hua-Ruanuku, University of Otago, PO Box 56, Dunedin, New Zealand
1 shared publicationAnneke Dorgelo
School of Molecular and Microbial Sciences, The University of Queensland, Queensland, Australia
1 shared publication
Latest Publications
- Open Access
- 1 December 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (50) , 41732-41743
Multiple Binding Sites on the Pyrin Domain of ASC Protein Allow Self-association and Interaction with NLRP3 Protein
- 1 December 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (50) , 41732-41743
Open AccessMultiple Binding Sites on the Pyrin Domain of ASC Protein Allow Self-association and Interaction with NLRP3 Protein
- 23 September 2008
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- No. 43,p. 6045-6054
A structural and catalytic model for zinc phosphoesterases
A structural model for the active site of phosphoesterases, enzymes that degrade organophosphate neurotoxins, has been synthesised. The ligand [2-((2-hydroxy-3-(((2-hydroxyethyl)(pyridin-2-ylmethyl)amino)methyl)-5-methylbenzyl)(pyridin-2-ylmethyl)amino)acetic acid] (H3L1) and two Zn(II) complexes have been prepared and characterised as [Zn2(HL1)(CH3COO)](PF6)·H2O and Li[Zn2(HL1)]4(PO4)2(PF6)3·(CH3OH). The ligand (H3L1) and complex [Zn2(HL1)(CH3COO)](PF6)·H2O were characterised through 1H NMR, 13C NMR, mass spectroscopy and microanalysis. The X-ray crystal structure of Li[Zn2(HL1)]4(PO4)2(PF6)3·(CH3OH) revealed a tetramer of dinuclear complexes, bridged by two phosphate molecules and bifurcating acetic acid arms. Functional studies of the zinc complex with the substrate bis(4-nitrophenyl)phosphate (bNPP) determined the complex with HL12− to be a competent catalyst with kcat = 1.26 ± 0.06 × 10−6 s−1.
- 23 September 2008
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- No. 43,p. 6045-6054
A structural and catalytic model for zinc phosphoesterases
A structural model for the active site of phosphoesterases, enzymes that degrade organophosphate neurotoxins, has been synthesised. The ligand [2-((2-hydroxy-3-(((2-hydroxyethyl)(pyridin-2-ylmethyl)amino)methyl)-5-methylbenzyl)(pyridin-2-ylmethyl)amino)acetic acid] (H3L1) and two Zn(II) complexes have been prepared and characterised as [Zn2(HL1)(CH3COO)](PF6)·H2O and Li[Zn2(HL1)]4(PO4)2(PF6)3·(CH3OH). The ligand (H3L1) and complex [Zn2(HL1)(CH3COO)](PF6)·H2O were characterised through 1H NMR, 13C NMR, mass spectroscopy and microanalysis. The X-ray crystal structure of Li[Zn2(HL1)]4(PO4)2(PF6)3·(CH3OH) revealed a tetramer of dinuclear complexes, bridged by two phosphate molecules and bifurcating acetic acid arms. Functional studies of the zinc complex with the substrate bis(4-nitrophenyl)phosphate (bNPP) determined the complex with HL12− to be a competent catalyst with kcat = 1.26 ± 0.06 × 10−6 s−1.
- 6 June 2008
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 13 (7) , 1065-1072
Cadmium(II) complexes of the glycerophosphodiester-degrading enzyme GpdQ and a biomimetic N,O ligand
The glycerophosphodiester-degrading enzyme GpdQ from Enterobacter aerogenes is a promising bioremediator owing to its ability to degrade some organophosphate pesticides and diester products originating from the hydrolysis of nerve agents such as VX. Here, the cadmium derivative of GpdQ was prepared by reconstituting the apoenzyme. Catalytic measurements with (Cd2+)2-GpdQ and the phosphodiester substrate bis(4-nitrophenyl)phosphate yield k cat = 15 s−1. The pK a of 9.4, determined from the pH dependence of the catalytic activity, implicates a hydroxide ligand as the catalytic nucleophile. Also prepared was the cadmium-containing biomimetic [Cd2((HP)2B)(OAc)2(OH2)](PF6) (where (HP)2B is [2,6-bis([(2-pyridylmethyl)(2-hydroxyethyl)amino]methyl)-4-methylphenol]), which mimics the asymmetry of the metal ion coordination in the active site of GpdQ. The phosphoesterase-like activity of [Cd2((HP)2B)(OAc)2(OH2)](PF6) was studied using the substrate bis(2,4-dinitrophenyl)phosphate, yielding a kinetically relevant pK a of 8.9, with k cat = 0.004 s−1. In summary, the model is both an adequate structural and a reasonable functional mimic of GpdQ.
- 6 June 2008
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 13 (7) , 1065-1072
Cadmium(II) complexes of the glycerophosphodiester-degrading enzyme GpdQ and a biomimetic N,O ligand
The glycerophosphodiester-degrading enzyme GpdQ from Enterobacter aerogenes is a promising bioremediator owing to its ability to degrade some organophosphate pesticides and diester products originating from the hydrolysis of nerve agents such as VX. Here, the cadmium derivative of GpdQ was prepared by reconstituting the apoenzyme. Catalytic measurements with (Cd2+)2-GpdQ and the phosphodiester substrate bis(4-nitrophenyl)phosphate yield k cat = 15 s−1. The pK a of 9.4, determined from the pH dependence of the catalytic activity, implicates a hydroxide ligand as the catalytic nucleophile. Also prepared was the cadmium-containing biomimetic [Cd2((HP)2B)(OAc)2(OH2)](PF6) (where (HP)2B is [2,6-bis([(2-pyridylmethyl)(2-hydroxyethyl)amino]methyl)-4-methylphenol]), which mimics the asymmetry of the metal ion coordination in the active site of GpdQ. The phosphoesterase-like activity of [Cd2((HP)2B)(OAc)2(OH2)](PF6) was studied using the substrate bis(2,4-dinitrophenyl)phosphate, yielding a kinetically relevant pK a of 8.9, with k cat = 0.004 s−1. In summary, the model is both an adequate structural and a reasonable functional mimic of GpdQ.
- 6 September 2007
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- No. 44,p. 5132-5139
Synthesis and characterization of the tetranuclear iron(iii) complex of a new asymmetric multidentate ligand. A structural model for purple acid phosphatases
The ligand, 2-((2-hydroxy-5-methyl-3-((pyridin-2-ylmethylamino)methyl)benzyl)(2-hydroxybenzyl)amino)acetic acid (H3HPBA), which contains a donor atom set that mimics that of the active site of purple acid phosphatase is described. Reaction of H3HPBA with iron(III) or iron(II) salts results in formation of the tetranuclear complex, [Fe4(HPBA)2(OAc)2(µ-O)(µ-OH)(OH2)2]ClO4·5H2O. X-Ray structural analysis reveals the cation consists of four iron(III) ions, two HPBA3− ligands, two bridging acetate ligands, a bridging oxide ion and a bridging hydroxide ion. Each binucleating HPBA3− ligand coordinates two structurally distinct hexacoordinate iron(III) ions. The two metal ions coordinated to a HPBA3− ligand are linked to the two iron(III) metal ions of a second, similar binuclear unit by intramolecular oxide and hydroxide bridging moieties to form a tetramer. The complex has been further characterised by elemental analysis, mass spectrometry, UV-vis and MCD spectroscopy, X-ray crystallography, magnetic susceptibility measurements and variable-temperature Mössbauer spectroscopy.
- 6 September 2007
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- No. 44,p. 5132-5139
Synthesis and characterization of the tetranuclear iron(iii) complex of a new asymmetric multidentate ligand. A structural model for purple acid phosphatases
The ligand, 2-((2-hydroxy-5-methyl-3-((pyridin-2-ylmethylamino)methyl)benzyl)(2-hydroxybenzyl)amino)acetic acid (H3HPBA), which contains a donor atom set that mimics that of the active site of purple acid phosphatase is described. Reaction of H3HPBA with iron(III) or iron(II) salts results in formation of the tetranuclear complex, [Fe4(HPBA)2(OAc)2(µ-O)(µ-OH)(OH2)2]ClO4·5H2O. X-Ray structural analysis reveals the cation consists of four iron(III) ions, two HPBA3− ligands, two bridging acetate ligands, a bridging oxide ion and a bridging hydroxide ion. Each binucleating HPBA3− ligand coordinates two structurally distinct hexacoordinate iron(III) ions. The two metal ions coordinated to a HPBA3− ligand are linked to the two iron(III) metal ions of a second, similar binuclear unit by intramolecular oxide and hydroxide bridging moieties to form a tetramer. The complex has been further characterised by elemental analysis, mass spectrometry, UV-vis and MCD spectroscopy, X-ray crystallography, magnetic susceptibility measurements and variable-temperature Mössbauer spectroscopy.